Hi @workingdog,
These numbers might interest you in light of your statement. This is a Quarterly wrapup of the sector for the Q4 period. I have also included the Aussie 5-year and Global 10-year Cannabis index as a summary which goes to your remarks, as well.
The only comment I have is that these Revenues are disgraceful after five years of business and are less than the double previous quarter's revenue that I would have been looking/hoping for after a rebranding with a soft launch. However, still, it indicates that the company has started again, as I believe they mentioned. There is still a lot of tidying up, but it is worth taking a close look a the distress the whole sector is in and why I previously mentioned a 10-year prove-up. The Aussie Index does show a slight turn up in the share price curve for July 1, now we are at 5 years.
Trying to find some glimmer of hope here, and looking at the negative cash flow, comparing them to the rest of the sector; if they can improve and double receipts again by the next quarter and keep operating costs low and maintain a healthy fwd funding, then they may be on target for signs of sustained profits profit by six quarters, i.e. Q1 -23/24. I will continue to be on the hammer and chase them over medications and also for the AGM later in the year where I will have my say in voting.
It was great to see Andrew Kavasilas still working with them.
AUSSIE CANNABIS INDEX
GLOBAL CANNABIS INDEX 10 YEARS
- Forums
- ASX - By Stock
- CGB
- Ann: Quarterly Activities/Appendix 4C Cash Flow Report
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-6
-
- There are more pages in this discussion • 152 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CGB (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
SER
STRATEGIC ENERGY RESOURCES LIMITED
David DeTata, Managing Director
David DeTata
Managing Director
SPONSORED BY The Market Online